2023-2029 Global Medications for Treating Alcohol Dependence Industry Research & Trends Analysis Report

Publication Month: Mar 2023 | No. of Pages: 147 Published By:
Single User License: US $ 3060
Corporate User License: US $ 5200

According to YH Research, the global market for Medications for Treating Alcohol Dependence
should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
China Medications for Treating Alcohol Dependence
market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
The United States Medications for Treating Alcohol Dependence
market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.
In terms of type, Naltrexone segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Hospital has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.
The global key manufacturers of Medications for Treating Alcohol Dependence
include Alkermes Inc, Merck Group, Lundbeck, Alvogen, Mylan, Teva, Sun Pharmaceutical Industries, Zydus Pharmaceuticals and Taj Pharmaceuticals, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.
This report aims to provide a comprehensive study of the global market for Medications for Treating Alcohol Dependence
. Report Highlights:
(1) Global Medications for Treating Alcohol Dependence
market size (value), history data from 2018-2022 and forecast data from 2023 to 2029.
(2) Global Medications for Treating Alcohol Dependence
market competitive situation, revenue and market share, from 2018 to 2022.
(3) China Medications for Treating Alcohol Dependence
market competitive situation, revenue and market share, from 2018 to 2022.
(4) Global Medications for Treating Alcohol Dependence
segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.
(5) Global Medications for Treating Alcohol Dependence
segment by type and by application and regional segment by type and by application.
(6) Medications for Treating Alcohol Dependence
industry supply chain, upstream, midstream and downstream analysis.
Market segment by regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa
Market segment by type, covers
Naltrexone
Acamprosate
Disulfiram
Other
Market segment by application, can be divided into
Hospital
Rehabilitation Institutions
Clinic
Retail Pharmacies
Market segment by players, this report covers
Alkermes Inc
Merck Group
Lundbeck
Alvogen
Mylan
Teva
Sun Pharmaceutical Industries
Zydus Pharmaceuticals
Taj Pharmaceuticals
TAGI Pharma Inc.
Beijing Wellso Pharmaceutical Co
Glenmark Pharmaceuticals
Rusan Pharma Ltd

1 Market Overview
1.1 Product Overview and Scope of Medications for Treating Alcohol Dependence

1.2 Global Medications for Treating Alcohol Dependence
Market Size and Forecast
1.3 China Medications for Treating Alcohol Dependence
Market Size and Forecast
1.4 China Market Percentage in Global
1.4.1 By Revenue, China Medications for Treating Alcohol Dependence
Share in Global Market, 2018-2029
1.4.2 Medications for Treating Alcohol Dependence
Market Size: China VS Global, 2018-2029
1.5 Medications for Treating Alcohol Dependence
Market Dynamics
1.5.1 Medications for Treating Alcohol Dependence
Market Drivers
1.5.2 Medications for Treating Alcohol Dependence
Market Restraints
1.5.3 Medications for Treating Alcohol Dependence
Industry Trends
1.5.4 Medications for Treating Alcohol Dependence
Industry Policy
2 Global Competitive Situation by Company
2.1 Global Medications for Treating Alcohol Dependence
Revenue by Company (2018-2023)
2.2 Global Medications for Treating Alcohol Dependence
Participants, Market Position (Tier 1, Tier 2 and Tier 3)
2.3 Global Medications for Treating Alcohol Dependence
Concentration Ratio
2.4 Global Medications for Treating Alcohol Dependence
Mergers & Acquisitions, Expansion Plans
2.5 Global Medications for Treating Alcohol Dependence
Manufacturers Product Type
3 China Competitive Situation by Company
3.1 China Medications for Treating Alcohol Dependence
Revenue by Company (2018-2023)
3.2 China Medications for Treating Alcohol Dependence
Medications for Treating Alcohol Dependence
Participants, Market Position (Tier 1, Tier 2 and Tier 3)
3.3 China Medications for Treating Alcohol Dependence
, Revenue Percentage of Local Players VS Foreign Manufacturers (2018-2023)
4 Industry Chain Analysis
4.1 Medications for Treating Alcohol Dependence
Industry Chain
4.2 Medications for Treating Alcohol Dependence
Upstream Analysis
4.3 Medications for Treating Alcohol Dependence
Midstream Analysis
4.4 Medications for Treating Alcohol Dependence
Downstream Analysis
5 Sights by Type
5.1 Medications for Treating Alcohol Dependence
Classification
5.1.1 Naltrexone
5.1.2 Acamprosate
5.1.3 Disulfiram
5.1.4 Other
5.2 By Type, Global Medications for Treating Alcohol Dependence
Market Size & CAGR, 2018 VS 2022 VS 2029
5.3 By Type, Global Medications for Treating Alcohol Dependence
Revenue, 2018-2029
6 Sights by Application
6.1 Medications for Treating Alcohol Dependence
Segment by Application
6.1.1 Hospital
6.1.2 Rehabilitation Institutions
6.1.3 Clinic
6.1.4 Retail Pharmacies
6.2 By Application, Global Medications for Treating Alcohol Dependence
Market Size & CAGR, 2018 VS 2022 VS 2029
6.3 By Application, Global Medications for Treating Alcohol Dependence
Revenue, 2018-2029
7 Sales Sights by Region
7.1 By Region, Global Medications for Treating Alcohol Dependence
Market Size, 2018 VS 2022 VS 2029
7.2 By Region, Global Medications for Treating Alcohol Dependence
Market Size, 2018-2029
7.3 North America
7.3.1 North America Medications for Treating Alcohol Dependence
Market Size & Forecasts, 2018-2029
7.3.2 By Country, North America Medications for Treating Alcohol Dependence
Market Size Market Share
7.4 Europe
7.4.1 Europe Medications for Treating Alcohol Dependence
Market Size & Forecasts, 2018-2029
7.4.2 By Country, Europe Medications for Treating Alcohol Dependence
Market Size Market Share
7.5 Asia Pacific
7.5.1 Asia Pacific Medications for Treating Alcohol Dependence
Market Size & Forecasts, 2018-2029
7.5.2 By Country/Region, Asia Pacific Medications for Treating Alcohol Dependence
Market Size Market Share
7.6 South America
7.6.1 South America Medications for Treating Alcohol Dependence
Market Size & Forecasts, 2018-2029
7.6.2 By Country, South America Medications for Treating Alcohol Dependence
Market Size Market Share
7.7 Middle East & Africa
8 Sights by Country Level
8.1 By Country, Global Medications for Treating Alcohol Dependence
Market Size & CAGR,2018 VS 2022 VS 2029
8.2 By Country, Global Medications for Treating Alcohol Dependence
Market Size, 2018-2029
8.3 U.S.
8.3.1 U.S. Medications for Treating Alcohol Dependence
Market Size, 2018-2029
8.3.2 By Company, U.S. Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2023
8.3.3 By Type, U.S. Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
8.3.4 By Application, U.S. Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
8.4 Europe
8.4.1 Europe Medications for Treating Alcohol Dependence
Market Size, 2018-2029
8.4.2 By Company, Europe Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2023
8.4.3 By Type, Europe Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
8.4.4 By Application, Europe Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
8.5 China
8.5.1 China Medications for Treating Alcohol Dependence
Market Size, 2018-2029
8.5.2 By Company, China Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2023
8.5.3 By Type, China Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
8.5.4 By Application, China Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
8.6 Japan
8.6.1 Japan Medications for Treating Alcohol Dependence
Market Size, 2018-2029
8.6.2 By Company, Japan Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2023
8.6.3 By Type, Japan Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
8.6.4 By Application, Japan Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
8.7 South Korea
8.7.1 South Korea Medications for Treating Alcohol Dependence
Market Size, 2018-2029
8.7.2 By Company, South Korea Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2023
8.7.3 By Type, South Korea Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
8.7.4 By Application, South Korea Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
8.8 Southeast Asia
8.8.1 Southeast Asia Medications for Treating Alcohol Dependence
Market Size, 2018-2029
8.8.2 By Company, Southeast Asia Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2023
8.8.3 By Type, Southeast Asia Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
8.8.4 By Application, Southeast Asia Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
8.9 India
8.9.1 India Medications for Treating Alcohol Dependence
Market Size, 2018-2029
8.9.2 By Company, India Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2023
8.9.3 By Type, India Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
8.9.4 By Application, India Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
8.10 Middle East & Asia
8.10.1 Middle East & Asia Medications for Treating Alcohol Dependence
Market Size, 2018-2029
8.10.2 By Company, Middle East & Asia Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2023
8.10.3 By Type, Middle East & Asia Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
8.10.4 By Application, Middle East & Asia Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
9 Global Manufacturers Profile
9.1 Alkermes Inc
9.1.1 Alkermes Inc Company Information, Head Office, Market Area and Industry Position
9.1.2 Alkermes Inc Company Profile and Main Business
9.1.3 Alkermes Inc Medications for Treating Alcohol Dependence
Models, Specifications and Application
9.1.4 Alkermes Inc Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
9.1.5 Alkermes Inc Recent Developments
9.2 Merck Group
9.2.1 Merck Group Company Information, Head Office, Market Area and Industry Position
9.2.2 Merck Group Company Profile and Main Business
9.2.3 Merck Group Medications for Treating Alcohol Dependence
Models, Specifications and Application
9.2.4 Merck Group Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
9.2.5 Merck Group Recent Developments
9.3 Lundbeck
9.3.1 Lundbeck Company Information, Head Office, Market Area and Industry Position
9.3.2 Lundbeck Company Profile and Main Business
9.3.3 Lundbeck Medications for Treating Alcohol Dependence
Models, Specifications and Application
9.3.4 Lundbeck Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
9.3.5 Lundbeck Recent Developments
9.4 Alvogen
9.4.1 Alvogen Company Information, Head Office, Market Area and Industry Position
9.4.2 Alvogen Company Profile and Main Business
9.4.3 Alvogen Medications for Treating Alcohol Dependence
Models, Specifications and Application
9.4.4 Alvogen Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
9.4.5 Alvogen Recent Developments
9.5 Mylan
9.5.1 Mylan Company Information, Head Office, Market Area and Industry Position
9.5.2 Mylan Company Profile and Main Business
9.5.3 Mylan Medications for Treating Alcohol Dependence
Models, Specifications and Application
9.5.4 Mylan Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
9.5.5 Mylan Recent Developments
9.6 Teva
9.6.1 Teva Company Information, Head Office, Market Area and Industry Position
9.6.2 Teva Company Profile and Main Business
9.6.3 Teva Medications for Treating Alcohol Dependence
Models, Specifications and Application
9.6.4 Teva Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
9.6.5 Teva Recent Developments
9.7 Sun Pharmaceutical Industries
9.7.1 Sun Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position
9.7.2 Sun Pharmaceutical Industries Company Profile and Main Business
9.7.3 Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence
Models, Specifications and Application
9.7.4 Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
9.7.5 Sun Pharmaceutical Industries Recent Developments
9.8 Zydus Pharmaceuticals
9.8.1 Zydus Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.8.2 Zydus Pharmaceuticals Company Profile and Main Business
9.8.3 Zydus Pharmaceuticals Medications for Treating Alcohol Dependence
Models, Specifications and Application
9.8.4 Zydus Pharmaceuticals Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
9.8.5 Zydus Pharmaceuticals Recent Developments
9.9 Taj Pharmaceuticals
9.9.1 Taj Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.9.2 Taj Pharmaceuticals Company Profile and Main Business
9.9.3 Taj Pharmaceuticals Medications for Treating Alcohol Dependence
Models, Specifications and Application
9.9.4 Taj Pharmaceuticals Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
9.9.5 Taj Pharmaceuticals Recent Developments
9.10 TAGI Pharma Inc.
9.10.1 TAGI Pharma Inc. Company Information, Head Office, Market Area and Industry Position
9.10.2 TAGI Pharma Inc. Company Profile and Main Business
9.10.3 TAGI Pharma Inc. Medications for Treating Alcohol Dependence
Models, Specifications and Application
9.10.4 TAGI Pharma Inc. Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
9.10.5 TAGI Pharma Inc. Recent Developments
9.11 Beijing Wellso Pharmaceutical Co
9.11.1 Beijing Wellso Pharmaceutical Co Company Information, Head Office, Market Area and Industry Position
9.11.2 Beijing Wellso Pharmaceutical Co Company Profile and Main Business
9.11.3 Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence
Models, Specifications and Application
9.11.4 Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
9.11.5 Beijing Wellso Pharmaceutical Co Recent Developments
9.12 Glenmark Pharmaceuticals
9.12.1 Glenmark Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
9.12.2 Glenmark Pharmaceuticals Company Profile and Main Business
9.12.3 Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence
Models, Specifications and Application
9.12.4 Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
9.12.5 Glenmark Pharmaceuticals Recent Developments
9.13 Rusan Pharma Ltd
9.13.1 Rusan Pharma Ltd Company Information, Head Office, Market Area and Industry Position
9.13.2 Rusan Pharma Ltd Company Profile and Main Business
9.13.3 Rusan Pharma Ltd Medications for Treating Alcohol Dependence
Models, Specifications and Application
9.13.4 Rusan Pharma Ltd Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
9.13.5 Rusan Pharma Ltd Recent Developments
10 Conclusion
11 Appendix
11.1 Research Methodology
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Market Estimation Model
11.4 Disclaimer

Tables and Figures

Table 1. Medications for Treating Alcohol Dependence
Market Size & CAGR: China VS Global, (US$ Million), 2018-2029
Table 2. Medications for Treating Alcohol Dependence
Market Restraints
Table 3. Medications for Treating Alcohol Dependence
Market Trends
Table 4. Medications for Treating Alcohol Dependence
Industry Policy
Table 5. Global Medications for Treating Alcohol Dependence
Revenue by Company (2018-2023) & (US$ million)
Table 6. Global Medications for Treating Alcohol Dependence
Revenue Market Share by Company (2018-2023)
Table 7. Global Medications for Treating Alcohol Dependence
Manufacturers Market Concentration Ratio (CR3 and HHI)
Table 8. Global Medications for Treating Alcohol Dependence
Mergers & Acquisitions, Expansion Plans
Table 9. Global Medications for Treating Alcohol Dependence
Manufacturers Product Type
Table 10. China Medications for Treating Alcohol Dependence
Revenue by Company (2018-2023) & (US$ million)
Table 11. China Medications for Treating Alcohol Dependence
Revenue Market Share by Company (2018-2023)
Table 12. Global Key Players of Medications for Treating Alcohol Dependence
Upstream (Raw Materials)
Table 13. Global Medications for Treating Alcohol Dependence
Typical Customers
Table 14. Medications for Treating Alcohol Dependence
Typical Distributors
Table 15. By Type, Global Medications for Treating Alcohol Dependence
Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 16. By Application, Global Medications for Treating Alcohol Dependence
Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million
Table 17. By Region, Global Medications for Treating Alcohol Dependence
Market Size, 2018 VS 2022 VS 2029, US$ Million
Table 18. By Region, Global Medications for Treating Alcohol Dependence
Revenue, 2018-2029, US$ Million
Table 19. By Country, Global Medications for Treating Alcohol Dependence
Revenue & CAGR,2018 VS 2022 VS 2029, US$ Million
Table 20. By Country, Global Medications for Treating Alcohol Dependence
Revenue, 2018-2029, US$ Million
Table 21. By Country, Global Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2029
Table 22. Alkermes Inc Company Information, Head Office, Market Area and Industry Position
Table 23. Alkermes Inc Company Profile and Main Business
Table 24. Alkermes Inc Medications for Treating Alcohol Dependence
Models, Specifications and Application
Table 25. Alkermes Inc Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
Table 26. Alkermes Inc Recent Developments
Table 27. Merck Group Company Information, Head Office, Market Area and Industry Position
Table 28. Merck Group Company Profile and Main Business
Table 29. Merck Group Medications for Treating Alcohol Dependence
Models, Specifications and Application
Table 30. Merck Group Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
Table 31. Merck Group Recent Developments
Table 32. Lundbeck Company Information, Head Office, Market Area and Industry Position
Table 33. Lundbeck Company Profile and Main Business
Table 34. Lundbeck Medications for Treating Alcohol Dependence
Models, Specifications and Application
Table 35. Lundbeck Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
Table 36. Lundbeck Recent Developments
Table 37. Alvogen Company Information, Head Office, Market Area and Industry Position
Table 38. Alvogen Company Profile and Main Business
Table 39. Alvogen Medications for Treating Alcohol Dependence
Models, Specifications and Application
Table 40. Alvogen Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
Table 41. Alvogen Recent Developments
Table 42. Mylan Company Information, Head Office, Market Area and Industry Position
Table 43. Mylan Company Profile and Main Business
Table 44. Mylan Medications for Treating Alcohol Dependence
Models, Specifications and Application
Table 45. Mylan Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
Table 46. Mylan Recent Developments
Table 47. Teva Company Information, Head Office, Market Area and Industry Position
Table 48. Teva Company Profile and Main Business
Table 49. Teva Medications for Treating Alcohol Dependence
Models, Specifications and Application
Table 50. Teva Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
Table 51. Teva Recent Developments
Table 52. Sun Pharmaceutical Industries Company Information, Head Office, Market Area and Industry Position
Table 53. Sun Pharmaceutical Industries Company Profile and Main Business
Table 54. Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence
Models, Specifications and Application
Table 55. Sun Pharmaceutical Industries Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
Table 56. Sun Pharmaceutical Industries Recent Developments
Table 57. Zydus Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 58. Zydus Pharmaceuticals Company Profile and Main Business
Table 59. Zydus Pharmaceuticals Medications for Treating Alcohol Dependence
Models, Specifications and Application
Table 60. Zydus Pharmaceuticals Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
Table 61. Zydus Pharmaceuticals Recent Developments
Table 62. Taj Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 63. Taj Pharmaceuticals Company Profile and Main Business
Table 64. Taj Pharmaceuticals Medications for Treating Alcohol Dependence
Models, Specifications and Application
Table 65. Taj Pharmaceuticals Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
Table 66. Taj Pharmaceuticals Recent Developments
Table 67. TAGI Pharma Inc. Company Information, Head Office, Market Area and Industry Position
Table 68. TAGI Pharma Inc. Company Profile and Main Business
Table 69. TAGI Pharma Inc. Medications for Treating Alcohol Dependence
Models, Specifications and Application
Table 70. TAGI Pharma Inc. Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
Table 71. TAGI Pharma Inc. Recent Developments
Table 72. Beijing Wellso Pharmaceutical Co Company Information, Head Office, Market Area and Industry Position
Table 73. Beijing Wellso Pharmaceutical Co Company Profile and Main Business
Table 74. Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence
Models, Specifications and Application
Table 75. Beijing Wellso Pharmaceutical Co Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
Table 76. Beijing Wellso Pharmaceutical Co Recent Developments
Table 77. Glenmark Pharmaceuticals Company Information, Head Office, Market Area and Industry Position
Table 78. Glenmark Pharmaceuticals Company Profile and Main Business
Table 79. Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence
Models, Specifications and Application
Table 80. Glenmark Pharmaceuticals Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
Table 81. Glenmark Pharmaceuticals Recent Developments
Table 82. Rusan Pharma Ltd Company Information, Head Office, Market Area and Industry Position
Table 83. Rusan Pharma Ltd Company Profile and Main Business
Table 84. Rusan Pharma Ltd Medications for Treating Alcohol Dependence
Models, Specifications and Application
Table 85. Rusan Pharma Ltd Medications for Treating Alcohol Dependence
Revenue and Gross Margin, 2018-2023
Table 86. Rusan Pharma Ltd Recent Developments
List of Figure
Figure 1. Medications for Treating Alcohol Dependence
Picture
Figure 2. Global Medications for Treating Alcohol Dependence
Industry Market Size and Forecast (US$ million) & (2018-2029)
Figure 3. China Medications for Treating Alcohol Dependence
Revenue and Forecast (US$ million) & (2018-2029)
Figure 4. 2018-2029 China Medications for Treating Alcohol Dependence
Market Share of Global
Figure 5. Global Medications for Treating Alcohol Dependence
Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 6. Global Medications for Treating Alcohol Dependence
Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2018-2023
Figure 7. China Medications for Treating Alcohol Dependence
Key Participants, Market Share, 2021 VS 2022 VS 2023
Figure 8. China Medications for Treating Alcohol Dependence
Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023
Figure 9. Medications for Treating Alcohol Dependence
Industry Chain
Figure 10. Naltrexone
Figure 11. Acamprosate
Figure 12. Disulfiram
Figure 13. Other
Figure 14. By Type, Global Medications for Treating Alcohol Dependence
Revenue, 2018-2029, US$ Million
Figure 15. By Type, Global Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2029
Figure 16. Hospital
Figure 17. Rehabilitation Institutions
Figure 18. Clinic
Figure 19. Retail Pharmacies
Figure 20. By Application, Global Medications for Treating Alcohol Dependence
Revenue, 2018-2029, US$ Million
Figure 21. By Application, Global Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2029
Figure 22. By Region, Global Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2029
Figure 23. North America Medications for Treating Alcohol Dependence
Revenue & Forecasts, 2018-2029, US$ Million
Figure 24. By Country, North America Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2023
Figure 25. Europe Medications for Treating Alcohol Dependence
Revenue & Forecasts, 2018-2029, US$ Million
Figure 26. By Country, Europe Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2023
Figure 27. Asia Pacific Medications for Treating Alcohol Dependence
Revenue & Forecasts, 2018-2029, US$ Million
Figure 28. By Country/Region, Asia Pacific Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2023
Figure 29. South America Medications for Treating Alcohol Dependence
Revenue & Forecasts, 2018-2029, US$ Million
Figure 30. By Country, South America Medications for Treating Alcohol Dependence
Revenue Market Share, 2018-2023
Figure 31. Middle East & Africa Medications for Treating Alcohol Dependence
Revenue & Forecasts, 2018-2029, US$ Million
Figure 32. U.S. Medications for Treating Alcohol Dependence
Revenue, 2018-2029, (US$ Million)
Figure 33. By Company, U.S. Medications for Treating Alcohol Dependence
Market Share, 2018-2023
Figure 34. By Type, U.S. Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 35. By Application, U.S. Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 36. Europe Medications for Treating Alcohol Dependence
Revenue, 2018-2029, (US$ Million)
Figure 37. By Company, Europe Medications for Treating Alcohol Dependence
Market Share, 2018-2023
Figure 38. By Type, Europe Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 39. By Application, Europe Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 40. China Medications for Treating Alcohol Dependence
Revenue, 2018-2029, (US$ Million)
Figure 41. By Company, China Medications for Treating Alcohol Dependence
Market Share, 2018-2023
Figure 42. By Type, China Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 43. By Application, China Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 44. Japan Medications for Treating Alcohol Dependence
Revenue, 2018-2029, (US$ Million)
Figure 45. By Company, Japan Medications for Treating Alcohol Dependence
Market Share, 2018-2023
Figure 46. By Type, Japan Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 47. By Application, Japan Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 48. South Korea Medications for Treating Alcohol Dependence
Revenue, 2018-2029, (US$ Million)
Figure 49. By Company, South Korea Medications for Treating Alcohol Dependence
Market Share, 2018-2023
Figure 50. By Type, South Korea Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 51. By Application, South Korea Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 52. Southeast Asia Medications for Treating Alcohol Dependence
Revenue, 2018-2029, (US$ Million)
Figure 53. By Company, Southeast Asia Medications for Treating Alcohol Dependence
Market Share, 2018-2023
Figure 54. By Type, Southeast Asia Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 55. By Application, Southeast Asia Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 56. India Medications for Treating Alcohol Dependence
Revenue, 2018-2029, (US$ Million)
Figure 57. By Company, India Medications for Treating Alcohol Dependence
Market Share, 2018-2023
Figure 58. By Type, India Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 59. By Application, India Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 60. Middle East & Asia Medications for Treating Alcohol Dependence
Revenue, 2018-2029, (US$ Million)
Figure 61. By Company, Middle East & Asia Medications for Treating Alcohol Dependence
Market Share, 2018-2023
Figure 62. By Type, Middle East & Asia Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 63. By Application, Middle East & Asia Medications for Treating Alcohol Dependence
Revenue Market Share, 2022 VS 2029
Figure 64. Research Methodology
Figure 65. Breakdown of Primary Interviews
Figure 66. Bottom-up Approaches
Figure 67. Top-down Approaches



Reason to Buy

  • Current and future of Pharma & Healthcare Market outlook in the developed and emerging markets
  • Highlights key business priorities in order to assist companies to realign their business strategies
  • The segment that is expected to dominate the Pharma & Healthcare Market
  • Regions that are expected to witness the fastest growth during the forecast period
  • Identify the latest developments, Pharma & Healthcare Market shares, and strategies employed by the major market players
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the global Pharma & Healthcare Market
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets